Genetic background affects function and intracellular calcium regulation of mouse hearts

Cardiovascular Research

Volumn 87, Issue 4, 2010, Pages 683-693

  Shah, Adarsh P ^a   Siedlecka, Urszula ^a   Gandhi, Ajay ^a   Navaratnarajah, Manoraj ^a   Abou Al Saud, Sara ^a,b   Yacoub, Magdi H ^a   Terracciano, Cesare M ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Ca 2+ spark; Ca2+ transient; EC coupling; Strain; Transgenic mice

Indexed keywords

CALCIUM ION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL STRUCTURE; CELL VOLUME; CIRCADIAN RHYTHM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EPIFLUORESCENCE MICROSCOPE; EXCITATION CONTRACTION COUPLING; GENETIC STRAIN; GENETIC VARIABILITY; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEART RATE; MALE; MOUSE; MUSCLE FIBER CONTRACTION; NONHUMAN; PRIORITY JOURNAL; SARCOMERE LENGTH; SARCOPLASMIC RETICULUM; TRANSVERSE TUBULAR SYSTEM;

ANIMALS; CALCIUM; CELL SIZE; CIRCADIAN RHYTHM; ELECTROCARDIOGRAPHY; EXCITATION CONTRACTION COUPLING; GENOTYPE; HEART RATE; HEART VENTRICLES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; MYOCARDIAL CONTRACTION; MYOCARDIUM; PHENOTYPE; SARCOPLASMIC RETICULUM; SPECIES SPECIFICITY; STROKE VOLUME; TELEMETRY; VENTRICULAR FUNCTION, LEFT;

EID: 77955887705     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq111     Document Type: Article

References (38)

1. van't Veer LJ, Bernards R. Enabling personalized cancer medicine through analysis of gene-expression patterns. Nature 2008; 452: 564-570.
2. Charron P, Komajda M. Genes and their polymorphisms in mono-and multifactorial cardiomyopathies: towards pharmacogenomics in heart failure. Pharmacogenomics 2002;3:367-378.
3. Franz WM, Muller OJ, Katus HA. Cardiomyopathies: from genetics to the prospect of treatment. Lancet 2001;358:1627-1637.
4. Boussy T, Paparella G, de Asmundis C, Sarkozy A, Chierchia GB, Brugada J et al. Genetic basis of ventricular arrhythmias. Cardiol Clin 2008;26:335-353.
5. Field LJ. Atrial natriuretic factor-SV40 T antigen transgenes produce tumors and cardiac arrhythmias in mice. Science 1988;239:1029-1033.
6. Takeishi Y, Walsh RA. Cardiac hypertrophy and failure: lessons learned from genetically engineered mice. Acta Physiol Scand 2001;173:103-111.
7. Wang QD, Bohlooly Y, Sjoquist PO. Murine models for the study of congestive heart failure: implications for understanding molecular mechanisms and for drug discovery. J Pharmacol Toxicol Methods 2004;50:163-174.
8. Killeen MJ, Thomas G, Sabir IN, Grace AA, Huang CL. Mouse models of human arrhythmia syndromes. Acta Physiol (Oxf) 2008;192:455-469.
9. London B. Cardiac arrhythmias: from (transgenic) mice to men. J Cardiovasc Electrophy-siol 2001;12:1089-1091.
10. Tamargo J, Caballero R, Nunez L, Gomez R, Vaquero M, Delpon E. Genetically engineered mice as a model for studying cardiac arrhythmias. Front Biosci 2007;12:22-38.
11. Song LS, Guia A, Muth JN, Rubio M, Wang SQ, Xiao RP et al. Ca(2+) signaling in cardiac myocytes overexpressing the alpha(1) subunit of L-type Ca(2+) channel. Circ Res 2002;90:174-181.
12. Santana LF, Kranias EG, Lederer WJ. Calcium sparks and excitation-contraction coupling in phospholamban-deficient mouse ventricular myocytes. J Physiol 1997;503.1: 21-29.
13. Hoit BD, Khoury SF, Kranias EG, Ball N, Walsh RA. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ Res 1995;77:632-637.
14. Andersson KB, Birkeland JA, Finsen AV, Louch WE, Sjaastad I, Wang Y et al. Moderate heart dysfunction in mice with inducible cardiomyocyte-specific excision of the Serca2 gene. J Mol Cell Cardiol 2009;47:180-187.
15. 2+ exchange: cardiac-specific knockout of NCX1. Circ Res 2004;95:604-611.
16. Cook SA, Clerk A, Sugden PH. Are transgenic mice the 'alkahest' to understanding myocardial hypertrophy and failure? J Mol Cell Cardiol 2009;46:118-129.
17. Barrick CJ, Rojas M, Schoonhoven R, Smyth SS, Threadgill DW. Cardiac response to pressure overload in 129S1/SvImJ and C57BL/6J mice: temporal-and background-dependent development of concentric left ventricular hypertrophy. Am J Physiol Heart Circ Physiol 2007;292:H2119-H2130.
18. Barrick CJ, Roberts RB, Rojas M, Rajamannan NM, Suitt CB, O'Brien KD et al. Reduced EGFR causes abnormal valvular differentiation leading to calcific aortic stenosis and left ventricular hypertrophy in C57BL/6J but not 129S1/SvImJ mice. Am J Physiol Heart Circ Physiol 2009;297:H65-H75.
19. Hintz KK, Norby FL, Duan J, Cinnamon MA, Doze VA, Ren J. Comparison of cardiac excitation-contraction coupling in isolated ventricular myocytes between rat and mouse. Comp Biochem Physiol A Mol Integr Physiol 2002;133:191-198. (Pubitemid 34879713)
20. Li Q, Fang CX, Nunn JM, Zhang J, LaCour KH, Ren J. Characterization of cardiomyo-cyte excitation-contraction coupling in the FVB/N-C57BL/6 intercrossed 'chocolate' brown mice. Life Sci 2006;80:187-192.
21. Stagg MA, Carter E, Sohrabi N, Siedlecka U, Soppa GK, Mead F et al. Cytoskeletal protein 4.1R affects repolarization and regulates calcium handling in the heart. Circ Res 2008;103:855-863.
22. 2+ homeostasis of isolated rat ventricular myocytes. Am J Physiol Heart Circ Physiol 2008;295:H1917-H1926.
23. 2+ content during the cardiac cycle in guinea pig and rat ventricular myocytes. Biophys J 1997;72:1319-1326.
24. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-3450.
25. Bassani JW, Bassani RA, Bers DM. Calibration of indo-1 and resting intracellular [Ca]i in intact rabbit cardiac myocytes. Biophys J 1995;68:1453-1460.
26. Soppa GK, Lee J, Stagg MA, Felkin LE, Barton PJ, Siedlecka U et al. Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure. Cardiovasc Res 2008;77:695-706.
27. Stagg MA, Malik AH, MacLeod KT, Terracciano CM. The effects of overexpression of the Na(+)/Ca(2+) exchanger on calcium regulation in hypertrophied mouse cardiac myocytes. Cell Calcium 2004;36:111-118.
28. Orchard C, Brette F. t-Tubules and sarcoplasmic reticulum function in cardiac ventricular myocytes. Cardiovasc Res 2008;77:237-244.
29. Young ME. The circadian clock within the heart: potential influence on myocardial gene expression, metabolism, and function. Am J Physiol Heart Circ Physiol 2006;290: H1-H16.
30. Shusterman V, Usiene I, Harrigal C, Lee JS, Kubota T, Feldman AM et al. Strain-specific patterns of autonomic nervous system activity and heart failure susceptibility in mice. Am J Physiol Heart Circ Physiol 2002;282:H2076-H2083.
31. Bers DM. Cardiac excitation-contraction coupling. Nature 2002;415:198-205.
32. 2+ sparks and local control theories for cardiac excitation-contraction coupling. Circ Res 1996;78:166-171.
33. 2+ release syn-chronicity in a mouse model of diabetic cardiomyopathy. Circ Res 2009;105:527-536.
34. 2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart. Cardiovasc Res 2007;73:631-640.
35. Suzuki M, Carlson KM, Marchuk DA, Rockman HA. Genetic modifier loci affecting survival and cardiac function in murine dilated cardiomyopathy. Circulation 2002; 105:1824-1829.
36. Schulze-Bahr E. Susceptibility genes and modifiers for cardiac arrhythmias. Prog Biophys Mol Biol 2008;98:289-300.
37. Taylor JS, Ellis GR. Racial differences in responses to drug treatment: implications for pharmacotherapy of heart failure. Am J Cardiovasc Drugs 2002;2:389-399.
38. McNamara DM. Emerging role of pharmacogenomics in heart failure. Curr Opin Cardiol 2008;23:261-268.